Tag Archives: US FDA AUTHORIZES PFIZER’S COVID BOOSTER SHOT FOR YOUNG CHILDREN

The US Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, the regulator said on Tuesday. The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine, although the U.S. Centers for Disease Control and Prevention (CDC) …

Read More »